Peritransplant profiles and survival outcomes of young adult patients who underwent liver transplantation for biliary atresia
Case No. | Recipient sex | Recipient age at LT (yr) | Age at KPE (mo) | Cause of LT | VB | HE | MELD score | CTP score | Platelet count (103/mL) | TB (mg/dL) | Alb (g/dL) | Cr (mg/dL) | PT INR | Graft type | Donor sex | Donor age (yr) | Graft weight (g) | GRWR | Recipient survival period (mo) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 18 | 3 | PH | N | Y | 24 | 13 | 179 | 21.0 | 1.7 | 0.40 | 2.46 | WL | M | 30 | 1,420 | 2.11 | 158 |
2 | F | 19 | 1 | PH | Y | N | 15 | 10 | 47 | 5.6 | 2.3 | 0.33 | 1.22 | ELL | M | 46 | 415 | 0.92 | 87 |
3 | M | 22 | 3 | IC | N | N | 12 | 8 | 368 | 3.9 | 3.7 | 0.71 | 0.96 | MRL | M | 23 | 1,060 | 1.31 | 73 |
4 | M | 20 | 2 | PH | Y | N | 8 | 6 | 59 | 0.8 | 4.1 | 0.71 | 1.10 | MRL | M | 21 | 830 | 1.36 | 68 |
5 | F | 20 | 1 | PH | N | N | 20 | 9 | 31 | 5.0 | 2.4 | 0.31 | 1.90 | WL | M | 66 | 1,400 | 1.73 | 61 |
6 | M | 33 | 3 | PH | Y | N | 19 | 9 | 73 | 15.0 | 2.2 | 0.63 | 1.33 | MRL | M | 25 | 823 | 1.37 | 42 |
7 | F | 22 | 2 | IC | N | N | 9 | 9 | 158 | 4.1 | 2.6 | 0.45 | 1.05 | MRL | M | 27 | 735 | 1.17 | 34 |
Mean | M=4, F=3 | 22.0±5.1 | 2.1±0.9 | PH=5, IC=2 | Y=3, N=4 | Y=1, N=6 | 15.3±6.0 | 9.1±2.1 | 130.7±118.9 | 7.91±7.22 | 2.71±0.86 | 0.51±0.17 | 1.43±0.55 | MRL=4, ELL=1, WL=2 | M=7 | 34.0±16.4 | 954.7±364.8 | 1.42±0.39 | 74.7±40.9 |
LT, liver transplantation; KPE, Kasai portoenterostomy; VB, variceal bleeding; HE, hepatic encephalopathy; MELD, model for end-stage liver disease; CTP, Child-Turcotte-Pugh; TB, total bilirubin; Alb, albumin; Cr, creatinine; PT, prothrombin time; INR, international normalized ratio; GRWR, graft-to-recipient weight ratio; PH, portal hypertension; IC, intractable cholangitis; N, no; Y, yes; WL, whole liver; ELL, extended left liver; MRL, modified right liver.